These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30187621)

  • 1. Screening haemodialysis patients for hepatitis C in Vietnam: The inconsistency between common hepatitis C virus serological and virological tests.
    Duong MC; McLaws ML
    J Viral Hepat; 2019 Jan; 26(1):25-29. PubMed ID: 30187621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients.
    Wong XZ; Gan CC; Mohamed R; Yahya R; Ganapathy S; Tan SS; Lim SK
    BMC Nephrol; 2020 Nov; 21(1):480. PubMed ID: 33187498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV-RNA Pcr Positivity In Hcv Antibody Negative Patients Undergoing Haemodialysis.
    Kiani IG; Khan AN; Butt B; Sabir S; Ejaz S; Perveen A; Ghani E
    J Ayub Med Coll Abbottabad; 2018; 30(3):397-400. PubMed ID: 30465373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study.
    Duong CM; Olszyna DP; McLaws ML
    BMC Public Health; 2015 Feb; 15():192. PubMed ID: 25886623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of combined detection of hepatitis C virus core antigen and antibodies to reduce the serological window-phase].
    Hmaïed F; Ben Mamou M; Arrouji Z; Slim A; Ben Redjeb S
    Pathol Biol (Paris); 2007 Mar; 55(2):121-6. PubMed ID: 16631320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical evaluation of HCV core antigen and interest for HCV screening in haemodialysis patients.
    Miedouge M; Saune K; Kamar N; Rieu M; Rostaing L; Izopet J
    J Clin Virol; 2010 May; 48(1):18-21. PubMed ID: 20233674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus core antigen is cost-effective in community-based screening of active hepatitis C infection in Taiwan.
    Wang JH; Chen CH; Chang CM; Feng WC; Lee CY; Lu SN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 3):504-508. PubMed ID: 31350109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis.
    Reddy AK; Dakshinamurty KV; Lakshmi V
    Indian J Med Microbiol; 2006 Jan; 24(1):55-7. PubMed ID: 16505558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occult hepatitis C virus infection among haemodialysis patients.
    Ali NK; Mohamed RR; Saleh BE; Alkady MM; Farag ES
    Arab J Gastroenterol; 2018 Sep; 19(3):101-105. PubMed ID: 30245116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
    Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
    Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients.
    Medhi S; Potukuchi SK; Polipalli SK; Swargiary SS; Deka P; Chaudhary A; Begum N; Hussain Z; Ahlawat RS; Kar P
    Clin Biochem; 2008 May; 41(7-8):447-52. PubMed ID: 18267117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of in vitro screening and diagnostic kits for hepatitis C virus infection.
    Momose H; Matsuoka S; Murayama A; Yamada N; Okuma K; Ikebe E; Hoshi Y; Muramatsu M; Wakita T; Toyota K; Kato T; Hamaguchi I
    J Clin Virol; 2018 Aug; 105():97-102. PubMed ID: 29940422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection.
    Reddy AK; Murthy KV; Lakshmi V
    Indian J Med Microbiol; 2005 Apr; 23(2):106-10. PubMed ID: 15928439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of a combined hepatitis C virus core antigen and anti-hepatitis C virus antibody test in different patient groups.
    Yang JF; Lin YY; Hsieh MH; Tsai CH; Liu SF; Yu ML; Dai CY; Huang JF; Lin WY; Lin ZY; Chen SC; Chuang WL
    Kaohsiung J Med Sci; 2011 Jul; 27(7):258-63. PubMed ID: 21757142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients.
    Ponnuvel S; Fletcher GJ; Anantharam R; Varughese S; David VG; Abraham P
    PLoS One; 2021; 16(4):e0250263. PubMed ID: 33886631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.